Free Trial
NYSE:CNMD

CONMED Q1 2025 Earnings Report

CONMED logo
$48.49 -2.49 (-4.88%)
Closing price 04/15/2025 03:59 PM Eastern
Extended Trading
$49.18 +0.69 (+1.42%)
As of 05:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CONMED EPS Results

Actual EPS
N/A
Consensus EPS
$0.81
Beat/Miss
N/A
One Year Ago EPS
N/A

CONMED Revenue Results

Actual Revenue
N/A
Expected Revenue
$313.38 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

CONMED Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Wednesday, April 30, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Remove Ads

CONMED Earnings Headlines

3 Reasons to Sell CNMD and 1 Stock to Buy Instead
Analysts Set CONMED Co. (NYSE:CNMD) Target Price at $77.20
Could this be the start of AI’s Second Wind?
We're living in unprecedented times. Most people think it's too late to get into AI right now … That the biggest profits are already off the table.
See More CONMED Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CONMED? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CONMED and other key companies, straight to your email.

About CONMED

CONMED (NYSE:CNMD), a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

View CONMED Profile

More Earnings Resources from MarketBeat